交易 Outlook Therapeutics, Inc. - OTLK CFD
加入收藏夹- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
交易條件
价差 | 0.13 | ||||||||
多头隔夜费
多头隔夜费
前往平台 | -0.026179% | ||||||||
空头隔夜费
空头隔夜费
前往平台 | 0.003957% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 5% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Outlook Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
“D”分數表示相對 ESG 表現較差,公開報告重要 ESG 數據的透明度不足。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Apr 22, 2024 | 8.02 | -0.14 | -1.72% | 8.16 | 8.30 | 7.76 |
Apr 19, 2024 | 8.09 | 0.03 | 0.37% | 8.06 | 8.53 | 7.96 |
Apr 18, 2024 | 8.22 | -0.34 | -3.97% | 8.56 | 8.76 | 8.06 |
Apr 17, 2024 | 8.55 | -0.27 | -3.06% | 8.82 | 9.17 | 8.50 |
Apr 16, 2024 | 8.70 | 0.34 | 4.07% | 8.36 | 8.98 | 8.34 |
Apr 15, 2024 | 8.57 | 0.11 | 1.30% | 8.46 | 8.71 | 8.37 |
Apr 12, 2024 | 8.67 | -0.29 | -3.24% | 8.96 | 9.11 | 8.56 |
Apr 11, 2024 | 9.00 | 0.19 | 2.16% | 8.81 | 9.24 | 8.70 |
Apr 10, 2024 | 8.92 | -0.06 | -0.67% | 8.98 | 9.06 | 8.47 |
Apr 9, 2024 | 9.23 | -0.08 | -0.86% | 9.31 | 9.89 | 8.98 |
Apr 8, 2024 | 9.24 | 0.08 | 0.87% | 9.16 | 9.39 | 8.80 |
Apr 5, 2024 | 9.21 | -0.15 | -1.60% | 9.36 | 9.54 | 9.01 |
Apr 4, 2024 | 9.46 | 0.35 | 3.84% | 9.11 | 9.81 | 8.68 |
Apr 3, 2024 | 9.06 | -0.40 | -4.23% | 9.46 | 10.00 | 8.96 |
Apr 2, 2024 | 9.65 | -0.56 | -5.48% | 10.21 | 10.81 | 8.79 |
Apr 1, 2024 | 10.17 | -2.11 | -17.18% | 12.28 | 12.71 | 9.95 |
Mar 28, 2024 | 11.86 | 2.85 | 31.63% | 9.01 | 12.61 | 9.01 |
Mar 27, 2024 | 9.33 | 0.07 | 0.76% | 9.26 | 10.45 | 8.67 |
Mar 26, 2024 | 8.63 | 0.55 | 6.81% | 8.08 | 8.90 | 8.07 |
Mar 25, 2024 | 8.46 | -0.20 | -2.31% | 8.66 | 8.82 | 7.66 |
Outlook Therapeutics, Inc. Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
Monday, May 13, 2024 | ||
时间(协调世界时) (UTC) 12:30 | 国家 US
| 事件 Q2 2024 Outlook Therapeutics Inc Earnings Release Q2 2024 Outlook Therapeutics Inc Earnings ReleaseForecast(预报) -上一页 - |
Monday, August 12, 2024 | ||
时间(协调世界时) (UTC) 12:30 | 国家 US
| 事件 Q3 2024 Outlook Therapeutics Inc Earnings Release Q3 2024 Outlook Therapeutics Inc Earnings ReleaseForecast(预报) -上一页 - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 8.14612 | 3.08756 |
收入 | 0 | 8.14612 | 3.08756 | ||
總營業費用 | 64.0962 | 51.7267 | 38.7369 | 45.0524 | 33.9842 |
銷售/一般/行政費用,總計 | 20.7399 | 12.7687 | 9.97102 | 9.36982 | 14.2278 |
研究與開發 | 42.3309 | 38.958 | 26.342 | 23.8053 | 18.504 |
營業收入 | -64.0962 | -51.7267 | -38.7369 | -36.9063 | -30.8967 |
利息收入(費用),非經營淨值 | -1.53619 | -0.98247 | -1.75647 | -3.46669 | -3.89125 |
其他,淨值 | -0.41712 | -0.45215 | 1.98194 | 2.4382 | 1.04773 |
稅前淨收入 | -66.0495 | -53.1614 | -38.5115 | -37.9348 | -33.7402 |
稅後淨收入 | -66.0523 | -53.1633 | -35.2395 | -34.5238 | -30.092 |
未計算非常項目前的淨收益 | -66.0523 | -53.1633 | -35.2395 | -34.5238 | -30.092 |
淨收入 | -66.0523 | -53.1633 | -35.2395 | -34.5238 | -30.092 |
Total Adjustments to Net Income | 0 | -13.6343 | -1.51588 | -17.9269 | |
普通股股東可獲收益 (不含非經常性項目) | -66.0523 | -53.1633 | -48.8738 | -36.0397 | -48.0188 |
普通股股東可獲收益 (含非經常性項目) | -66.0523 | -53.1633 | -48.8738 | -36.0397 | -48.0188 |
攤薄淨收入 | -66.0523 | -53.1633 | -48.8738 | -36.0397 | -48.0188 |
攤薄後加權平均股 | 212.079 | 152.676 | 72.5556 | 18.1918 | 4.93221 |
扣除特別項目的每股攤薄盈利 | -0.31145 | -0.34821 | -0.6736 | -1.98109 | -9.73577 |
Dividends per Share - Common Stock Primary Issue | |||||
每股正常攤薄盈利 | -0.30831 | -0.34821 | -0.65189 | -1.55671 | -9.57073 |
異常費用(收入) | 1.0254 | 0 | 2.42392 | 11.8773 | 1.25235 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
收入 | |||||
總營業費用 | 18.1414 | 6.83793 | 16.2657 | 13.9875 | 17.024 |
銷售/一般/行政費用,總計 | 7.0399 | 6.29298 | 5.8256 | 4.99801 | 5.77477 |
研究與開發 | 11.1015 | 0.54495 | 9.86242 | 8.98952 | 11.2492 |
異常費用(收入) | 0 | 0 | 0.57766 | 0 | |
營業收入 | -18.1414 | -6.83793 | -16.2657 | -13.9875 | -17.024 |
利息收入(費用),非經營淨值 | 0.38805 | 0.17082 | -2.42708 | -0.36788 | -0.36876 |
其他,淨值 | -2.92175 | 0.01562 | 0.03026 | 0.01118 | -0.14725 |
稅前淨收入 | -20.6751 | -6.65149 | -18.6625 | -14.3442 | -17.54 |
稅後淨收入 | -20.6751 | -6.65429 | -18.6625 | -14.345 | -17.54 |
未計算非常項目前的淨收益 | -20.6751 | -6.65429 | -18.6625 | -14.345 | -17.54 |
淨收入 | -20.6751 | -6.65429 | -18.6625 | -14.345 | -17.54 |
普通股股東可獲收益 (不含非經常性項目) | -20.6751 | -6.65429 | -18.6625 | -14.345 | -17.54 |
普通股股東可獲收益 (含非經常性項目) | -20.6751 | -6.65429 | -18.6625 | -14.345 | -17.54 |
攤薄淨收入 | -20.6751 | -6.65429 | -18.6625 | -14.345 | -17.54 |
攤薄後加權平均股 | 256.882 | 256.667 | 227.411 | 220.994 | 220.498 |
扣除特別項目的每股攤薄盈利 | -0.08048 | -0.02593 | -0.08207 | -0.06491 | -0.07955 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.08048 | -0.02593 | -0.07953 | -0.06491 | -0.07955 |
Total Adjustments to Net Income |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 27.5205 | 21.5082 | 17.9439 | 13.5016 | 3.30248 |
現金和短期投資 | 17.3968 | 14.4773 | 12.536 | 8.01553 | 1.71739 |
现金 | 17.3968 | 14.4773 | 12.536 | 8.01553 | 1.71739 |
預付的費用 | 10.1236 | 7.03082 | 5.40788 | 4.98603 | 1.58509 |
總資産 | 28.5278 | 22.8114 | 19.7325 | 17.135 | 22.2835 |
物業/廠房/設備,總計 - 淨額 | 0.07036 | 0.27505 | 0.49424 | 3.17596 | 18.49 |
物業/廠房/設備,總計 - 總額 | 1.06735 | 1.06735 | 1.23434 | 4.22744 | 30.1893 |
累計折舊,總計 | -1.06735 | -0.90373 | -0.7401 | -1.05148 | -11.6993 |
其他長期資産,總計 | 0.13202 | 0.17459 | 0.39445 | 0.45748 | 0.49104 |
流動負債總額 | 19.7298 | 6.75222 | 15.8888 | 20.2902 | 32.042 |
應付賬款 | 3.49149 | 2.19635 | 2.39482 | 2.27782 | 3.60961 |
預提費用 | 3.4549 | 1.76858 | 7.9448 | 4.62299 | 6.45847 |
應付票據/短期債務 | 0 | 0 | 0 | 6.699 | 13.1795 |
長期債務的當前部分/資本租賃 | 10.9268 | 0.93066 | 3.69256 | 4.83096 | 5.19977 |
其他流動負債,總計 | 1.85663 | 1.85663 | 1.85663 | 1.85943 | 3.59473 |
負債總額 | 19.7912 | 18.204 | 16.9063 | 27.9049 | 43.094 |
長期債務總額 | 0.00427 | 10.9019 | 0.94668 | 3.41608 | 3.55174 |
長期債務 | 0 | 10.8858 | 0.9042 | 0.05029 | 0.09849 |
資本租賃義務 | 0.00427 | 0.01602 | 0.04248 | 3.36579 | 3.45326 |
其他負債,總計 | 0.05714 | 0.54991 | 0.07077 | 4.19868 | 7.50023 |
總權益 | 8.73657 | 4.60745 | 2.82629 | -10.77 | -20.8105 |
Redeemable Preferred Stock | 0 | 0 | 0 | 5.3594 | 4.73442 |
普通股 | 2.27311 | 1.76462 | 1.27183 | 0.2861 | 0.7222 |
額外實收資本 | 415.399 | 345.726 | 291.274 | 238.065 | 190.04 |
留存收益(累計赤字) | -408.936 | -342.883 | -289.72 | -254.48 | -216.307 |
總負債和股東權益 | 28.5278 | 22.8114 | 19.7325 | 17.135 | 22.2835 |
已發行普通股總數 | 227.311 | 176.462 | 127.183 | 28.61 | 9.02754 |
Total Preferred Shares Outstanding | 0 | 0 | 0.06645 | 0.0602 | |
其他流動資産,總計 | 0 | 0.5 | |||
長期投資 | 0.80493 | 0.85366 | 0.9 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
流動資産總額 | 43.0181 | 53.0521 | 61.676 | 27.5205 | 37.5134 |
現金和短期投資 | 33.7091 | 43.6291 | 52.3409 | 17.3968 | 26.0214 |
现金 | 17.3968 | 26.0214 | |||
預付的費用 | 9.30906 | 9.42303 | 9.33512 | 10.1236 | 11.492 |
總資産 | 44.4472 | 54.024 | 62.6884 | 28.5278 | 38.5877 |
物業/廠房/設備,總計 - 淨額 | 0.03739 | 0.04858 | 0.05958 | 0.07036 | 0.12183 |
物業/廠房/設備,總計 - 總額 | 1.06735 | 1.06735 | |||
累計折舊,總計 | -1.06735 | -1.02645 | |||
長期投資 | 0.80228 | 0.80947 | 0.82644 | 0.80493 | 0.81216 |
其他長期資産,總計 | 0.58937 | 0.11385 | 0.12644 | 0.13202 | 0.14036 |
流動負債總額 | 49.93 | 43.528 | 15.0819 | 19.7298 | 18.43 |
應付賬款 | 5.05541 | 3.61975 | 4.16988 | 3.49149 | 2.48087 |
預提費用 | 8.27762 | 6.21833 | 9.04321 | 3.4549 | 3.61874 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 34.7403 | 31.8333 | 0.01214 | 10.9268 | 10.4737 |
其他流動負債,總計 | 1.85663 | 1.85663 | 1.85663 | 1.85663 | 1.85663 |
負債總額 | 49.95 | 43.5363 | 46.9298 | 19.7912 | 18.5056 |
長期債務總額 | 0 | 0 | 31.8211 | 0.00427 | 0.00735 |
長期債務 | 0 | 31.82 | 0 | 0 | |
資本租賃義務 | 0 | 0 | 0.00108 | 0.00427 | 0.00735 |
其他負債,總計 | 0.02001 | 0.00826 | 0.02688 | 0.05714 | 0.06832 |
總權益 | -5.50284 | 10.4877 | 15.7586 | 8.73657 | 20.0821 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
普通股 | 2.58704 | 2.56667 | 2.56667 | 2.27311 | 2.25943 |
額外實收資本 | 446.838 | 442.173 | 440.79 | 415.399 | 412.413 |
留存收益(累計赤字) | -454.927 | -434.252 | -427.598 | -408.936 | -394.59 |
總負債和股東權益 | 44.4472 | 54.024 | 62.6884 | 28.5278 | 38.5877 |
已發行普通股總數 | 258.704 | 256.667 | 256.667 | 227.311 | 225.943 |
Total Preferred Shares Outstanding | |||||
現金等價物 | 33.7091 | 43.6291 | 52.3409 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | -66.0523 | -53.1633 | -35.2395 | -34.5238 | -30.092 |
经营活动产生的现金 | -56.6746 | -54.2533 | -31.7901 | -32.29 | -33.0395 |
经营活动产生的现金 | 0.20469 | 0.26214 | 0.55407 | 3.36187 | 3.05435 |
非现金物品 | 10.8574 | 5.72732 | 4.16506 | 12.0668 | 7.68004 |
Cash Taxes Paid | 0 | ||||
已付现金利息 | 1.55669 | 0.04624 | 0.91397 | 2.79457 | 0.10998 |
营运资金的变化 | -1.68439 | -7.0794 | -1.26972 | -13.1949 | -13.6819 |
投资活动产生的现金 | 0 | -0.9 | -0.43731 | -2.78113 | |
资本支出 | 0 | -0.43731 | -2.78113 | ||
融资活动产生的现金 | 59.5941 | 56.1946 | 37.2105 | 39.0254 | 34.3525 |
融资现金流项目 | -0.6 | -0.00803 | 0 | -1.08916 | |
股票的发行(报废),净额 | 62.5132 | 49.8952 | 36.5696 | 45.9692 | 36.4323 |
债务的发行(退还),净额 | -2.31911 | 6.30744 | 0.64092 | -6.94374 | -0.99064 |
现金净变化 | 2.91949 | 1.94134 | 4.52046 | 6.29814 | -1.46813 |
其他投资现金流量项目,总计 | 0 | -0.9 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -25.3168 | -18.6625 | -66.0523 | -51.7072 | -34.1673 |
Cash From Operating Activities | -17.0159 | -8.90125 | -56.6746 | -46.4239 | -25.3246 |
Cash From Operating Activities | 0.02178 | 0.01078 | 0.20469 | 0.15322 | 0.10195 |
Non-Cash Items | 4.67426 | 3.28951 | 10.8574 | 9.02962 | 7.0661 |
Cash Interest Paid | 1.15901 | 1.15901 | 1.55669 | 1.55609 | 0.02202 |
Changes in Working Capital | 3.60489 | 6.46098 | -1.68439 | -3.89948 | 1.67459 |
Cash From Financing Activities | 43.2481 | 43.8453 | 59.5941 | 57.968 | 69.2714 |
Financing Cash Flow Items | -0.82389 | -0.56893 | -0.6 | -0.6 | -0.6 |
Issuance (Retirement) of Stock, Net | 24.2977 | 24.637 | 62.5132 | 60.8814 | 60.5884 |
Issuance (Retirement) of Debt, Net | 19.7743 | 19.7772 | -2.31911 | -2.31343 | 9.28301 |
Net Change in Cash | 26.2323 | 34.944 | 2.91949 | 11.5441 | 43.9468 |
Cash From Investing Activities | |||||
Other Investing Cash Flow Items, Total |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Outlook Therapeutics, Inc. Company profile
关于 Outlook Therapeutics Inc
Outlook Therapeutics, Inc.(Outlook)是一家处于临床阶段的生物制药公司。 公司专注于开发和商业化ONS-5010 (LYTENAVA (bevacizumab-vikg)),一种用于视网膜适应症的贝伐珠单抗的眼科配方。 ONS-5010是公司的候选产品,被开发为玻璃体内注射,用于治疗湿性年龄相关性黄斑变性(湿性AMD)和其他视网膜疾病。 贝伐单抗是一种全长的人源化抗VEGF(血管内皮生长因子)重组单克隆抗体(mAb),可抑制VEGF和相关血管生成活性。 其ONS-5010用于湿性AMD的临床计划包括三项临床试验,其中包括NORSE ONE、NORSE TWO和NORSE THREE。 Outlook在美国、英国、欧洲、日本和其他市场销售ONS-5010,用于治疗湿性AMD、糖尿病黄斑水肿(DME)和视网膜分支静脉阻塞(BRVO)。
Industry: | Biotechnology & Medical Research (NEC) |
485 Route 1 South
Building F, Suite 320
ISELIN
NEW JERSEY 08830
US
收入報表
- Annual
- Quarterly
人們也觀看
还在找一位您可以信任的经纪商吗?
加入成为全球610,000万多名交易者的一份子,选择利用Capital.com进行交易吧。